http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008122471-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2006-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008122471-A |
| titleOfInvention | METHOD FOR TREATING ABNORMAL CELL GROWTH |
| abstract | 1. A method of treating abnormal cell growth in a mammal in need of such treatment, comprising administering to said mammal a therapeutically effective amount of (R) -3- [1- (2,6-dichloro-3-fluorophenyl) ethoxy] -5- ( 1-piperidin-4-yl-1H-pyrazol-4-yl) pyridin-2-ylamine or a pharmaceutically acceptable salt thereof. ! 2. The method according to claim 1, where the mammal is a human. ! 3. The method according to claim 1, where the mammal is a dog. ! 4. The method according to any one of claims 1 to 3, where the abnormal cell growth is mediated by at least one genetically modified tyrosine kinase. ! 5. The method according to any one of claims 1 to 3, where the abnormal cell growth is mediated by hepatocyte growth factor receptor kinase (c-Met / HGFR) or anaplastic lymphoma kinase (ALK). ! 6. The method according to claim 5, where the abnormal cell growth is mediated by hepatocyte growth factor receptor kinase kinase (c-Met / HGFR). ! 7. The method according to claim 5, where the abnormal cell growth is mediated by anaplastic lymphoma kinase (ALK). ! 8. The method according to any one of claims 1 to 3, where the abnormal cell growth is cancer. ! 9. The method of claim 8, where the cancer is selected from lung cancer, bone cancer, pancreatic cancer, skin cancer, head or neck cancer, cutaneous or intraocular melanoma, uterine cancer, ovarian cancer, rectal cancer, anal cancer, stomach cancer , colon cancer, breast cancer, fallopian tube carcinoma, endometrial carcinoma, cervical carcinoma, vaginal carcinoma, vulva carcinoma, Hodgkin's disease, esophageal cancer, small intestine cancer, endocrine cancer, thyroid cancer, parathyroid cancer, adrenal cancer sarcoma m soft tissue, cancer of the urethra, cancer of the penis, prostate cancer, chronic or acute Lake |
| priorityDate | 2005-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.